VanEck Pharmaceutical ETF (PPH) is a VanEck ETF with a 0.36% expense ratio, 25 holdings and $1.1B in net assets. Largest sector: Healthcare (100%).
Fee
0.36%
expense ratio
Net assets
$1.1B
Launched
Dec 20, 2011
Holdings
25
as of Oct 22, 2026
Top 10 weight
71.8%
largest ten holdings
Largest sector
Healthcare
100.0%
Yield
30-day SEC 1.67% · TTM 2.53%
as of Oct 25, 2026
Benchmark
MVIS U.S. Listed Pharmaceutical 25 Index
PPH's holdings are as of Oct 22, 2026.
Healthcare
100.0%
1
LLY
ELI LILLY
21.84%
2
MRK
MERCK
12.62%
3
NVO
Novo Nordisk A/S
5.44%
4
PFE
PFIZER
5.14%
5
MCK
MCKESSON
4.80%
6
BMY
BRISTOL-MYERS SQUIBB
4.60%
7
TEVA
TEVA PHARMACEUTICAL IND LTD
4.51%
8
GSK
GLAXOSMITHKLINE CAPITAL
4.45%
9
COR
CENCORA
4.43%
10
HLN
HALEON
3.98%
11
ABBV
ABBVIE
3.70%
12
NVS
NOVARTIS AG ADR
3.70%
13
AZN
ASTRAZENECA
3.58%
14
JNJ
JOHNSON + JOHNSON
3.26%
15
SNY
Sanofi Sa/France
3.18%
16
TAK
TAKEDA PHARMACEUTIC SP ADR ADR
2.84%
17
ZTS
ZOETIS
2.71%
18
VTRS
VIATRIS
1.46%
19
JAZZ
Jazz Pharmaceuticals
1.14%
20
CORT
Corcept Therapeutics
0.67%
21
AXSM
Axsome Therapeutics
0.58%
22
ELAN
Elanco Animal Health
0.47%
23
DFTX
DEFINIUM THERAPEUTICS
0.43%
24
OGN
Organon
0.27%
25
PRGO
Perrigo
0.11%
1–25 of 25
Funds listed by how much of their largest holdings they share with PPH — not a ranking.
Data from VanEck; prices and returns from market data. Page updated October 29, 2026. Holdings and figures change over time. For information only — not investment advice.